Research Purposes Only

FOX04-DRI 10mg (FOXO4-DRI) lyophilised research peptide vial — UK lab-tested, for research use only

Copper & Collagen Peptides

FOX04-DRI

10mg

C₁₀₆H₁₄₁N₂₁O₂₈S₂

Key Research Findings

  • Baar et al. — characterisation of the FOXO4-binding D-retro-inverso peptide.
  • Published cell-culture studies on p21 and p16 senescence-marker transcription.
  • Animal-model in-vitro data on p53 nuclear-export pathway.

Overview

FOX04-DRI is a synthetic D-retro-inverso peptide designed to interfere with the FOXO4–p53 protein-protein interaction. Supplied as a lyophilised powder for in-vitro research use only.

Mechanism of Action

Reported in published in-vitro studies as a competitive binder of FOXO4 that releases nuclear-sequestered p53 in cell-culture senescence-model assays. Not intended for human or veterinary use.

Research Effects

FOXO4–p53 Interaction Assays

Moderate Research

Reported in cell-culture assays as a competitive disruptor of the FOXO4–p53 protein-protein interaction.

Senescence-Marker Studies

Moderate Research

Published in-vitro studies report changes in p21 and p16 transcription in cultured cells.

Apoptosis Cell-Culture Assays

Preliminary Research

Early-stage in-vitro apoptosis-marker studies in senescence cell models.

Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.

Quick Facts

Molecular FormulaC₁₀₆H₁₄₁N₂₁O₂₈S₂
Molecular Weight2246.51 g/mol
CAS Number2088986-26-7
Half-Life~24+ hours (animal pharmacokinetic data)
SolubilityWater/DMSO
Storage−20 °C
More in Copper & Collagen Peptides

Research Status Key

Extensive Research
Moderate Research
Preliminary Research

Related Peptides

How can we help?
Cart